Creating a new model to study and treat Cushing's disease
Development and Standardization of a Novel Pituitary Adenoma Organoid Model for the Study and Treatment of Cushing's Disease
['FUNDING_R01'] · UNIVERSITY OF GEORGIA · NIH-11093325
This study is creating a new lab model of pituitary tumors that cause Cushing's disease, so researchers can better understand the condition and find more effective treatments for patients like you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF GEORGIA (nih funded) |
| Locations | 1 site (ATHENS, UNITED STATES) |
| Trial ID | NIH-11093325 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel organoid model that mimics pituitary adenomas, which are tumors that cause Cushing's disease by producing excess adrenocorticotropic hormone (ACTH). By using this advanced 3D cell culture technique, researchers aim to better understand the disease and test new treatment options that are more effective than current therapies. The goal is to create a preclinical model that accurately reflects the complexity of the tumor tissue, which could lead to improved therapeutic strategies for patients suffering from Cushing's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Cushing's disease, particularly those who have not responded well to existing treatments.
Not a fit: Patients with Cushing's disease who have already achieved remission or those with other unrelated health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted treatments for patients with Cushing's disease, improving their quality of life and health outcomes.
How similar studies have performed: While the approach of using organoid models is gaining traction, this specific application for Cushing's disease is relatively novel and has not been extensively tested in prior research.
Where this research is happening
ATHENS, UNITED STATES
- UNIVERSITY OF GEORGIA — ATHENS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZAVROS, YANA — UNIVERSITY OF GEORGIA
- Study coordinator: ZAVROS, YANA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anterior Pituitary Hyposecretion Syndrome